2 results
Approved WMOCompleted
The primary objective of the study is to determine the rate of majorbleeding events in cancer subjects receiving extended treatment withdalteparin (> 6 months and up to 12 months) for prevention ofrecurrent symptomatic venous thromboembolism…
Approved WMOWill not start
To evaluate the efficacy, safety and PK of solifenacin succinate suspension after multiple dose administration.